Weight-loss stocks get a boost from new Biden proposal on drug coverage

By MarketWatch   |   1 year ago
Weight-loss stocks get a boost from new Biden proposal on drug coverage

Stocks of Novo Nordisk, Eli Lilly, and Viking Therapeutics rose premarket due to a proposed rule allowing Medicare to cover new obesity and diabetes drugs. This may lead to conflict between the pharmaceutical industry and Robert F. Kennedy Jr.

Read More

Did you find this insightful?